Breaking News Instant updates and real-time market news.

PSX

Phillips 66

$60.59 /

+3.33 (+5.82%)

13:05
04/07/20
04/07
13:05
04/07/20
13:05

Phillips 66 call volume above normal and directionally bullish

Bullish option flow detected in Phillips 66 with 1,697 calls trading, 1.7x expected, and implied vol increasing almost 4 points to 72.21%. Apr-20 60 calls and Apr-20 65 calls are the most active options, with total volume in those strikes near 500 contracts. The Put/Call Ratio is 0.19. Earnings are expected on May 1st.

  • 01

    May

  • 06

    May

PSX Phillips 66
$60.59 /

+3.33 (+5.82%)

03/29/20 RBC Capital
Phillips 66 upgraded to Outperform from Sector Perform at RBC Capital
03/26/20 Jefferies
Jefferies cuts Midstream & Refining estimates, but upgrades 5 'attractive' names
03/26/20 Jefferies
Phillips 66 upgraded to Buy from Hold at Jefferies
03/24/20 Raymond James
Phillips 66 price target lowered to $69 from $110 at Raymond James

TODAY'S FREE FLY STORIES

Hot Stocks
Deciphera presents data from cohort of Part 2 of rebastinib Phase 1b/2 at ASCO » 08:23
05/29/20
05/29
08:23
05/29/20
08:23
DCPH

Deciphera

$56.94 /

-1.77 (-3.01%)

Deciphera Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

05/18/20 SunTrust
Deciphera price target raised to $91 from $82 at SunTrust
05/18/20 Barclays
Deciphera price target raised to $85 from $80 at Barclays
05/18/20 Piper Sandler
Piper Sandler a buyer of Deciphera shares on the open
05/15/20 Piper Sandler
Deciphera's Ripretinib approved 3 months ahead of schedule, says Piper Sandler
DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

DCPH Deciphera
$56.94 /

-1.77 (-3.01%)

Technical Analysis
Utilities SPDR: Pivot points » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
XLU

Utilities SPDR

$59.26 /

+1.74 (+3.03%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLU Utilities SPDR
$59.26 /

+1.74 (+3.03%)

01/15/20 Goldman Sachs
Avangrid downgraded to Sell from Neutral at Goldman Sachs
XLU Utilities SPDR
$59.26 /

+1.74 (+3.03%)

XLU Utilities SPDR
$59.26 /

+1.74 (+3.03%)

Hot Stocks
Gilead announces results from interim analysis of ZUMA-5 » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
GILD

Gilead

$75.37 /

+0.42 (+0.56%)

Kite, a Gilead company,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/27/20 RBC Capital
Pullback in Gilead stock offers more attractive opportunity, says RBC Capital
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

Technical Analysis
Consumer Staples Sector SPDR: Pivot points » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
XLP

Consumer Staples Sector SPDR

$59.15 /

+0.48 (+0.82%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLP Consumer Staples Sector SPDR
$59.15 /

+0.48 (+0.82%)

10/23/19 Morgan Stanley
Procter & Gamble results could bode well for Walmart, says Morgan Stanley
XLP Consumer Staples Sector SPDR
$59.15 /

+0.48 (+0.82%)

Hot Stocks
Atossa Therapeutics announces publication on SARS-CoV-2 » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
ATOS

Atossa Therapeutics

$2.28 /

+0.085 (+3.87%)

Dr. Steven Quay, MD, PhD,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATOS Atossa Therapeutics
$2.28 /

+0.085 (+3.87%)

ATOS Atossa Therapeutics
$2.28 /

+0.085 (+3.87%)

12/18/19 Maxim
Atossa Genetics upgraded to Buy from Hold at Maxim
06/27/19 Maxim
Maxim downgrades Atossa Genetics to Hold on high endoxifen discontinuations
06/27/19 Maxim
Atossa Genetics downgraded to Hold from Buy at Maxim
ATOS Atossa Therapeutics
$2.28 /

+0.085 (+3.87%)

Technical Analysis
Health Care Select Sector SPDR: Pivot points » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
XLV

Health Care Select Sector SPDR

$101.77 /

+1.32 (+1.31%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLV Health Care Select Sector SPDR
$101.77 /

+1.32 (+1.31%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLV Health Care Select Sector SPDR
$101.77 /

+1.32 (+1.31%)

XLV Health Care Select Sector SPDR
$101.77 /

+1.32 (+1.31%)

Conference/Events
8x8, Inc.participates in a conference call hosted by Craig Hallum » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
EGHT

8x8, Inc.

$14.95 /

-0.515 (-3.33%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

05/13/20 Northland
8x8, Inc. price target lowered to $23 from $29 at Northland
05/13/20 B. Riley FBR
8x8, Inc. price target lowered to $12 from $13 at B. Riley FBR
05/13/20 Baird
8x8, Inc. price target lowered to $23 from $29 at Baird
05/13/20 BTIG
8x8, Inc. price target raised to $23 from $20 at BTIG
EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

EGHT 8x8, Inc.
$14.95 /

-0.515 (-3.33%)

Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points » 08:22
05/29/20
05/29
08:22
05/29/20
08:22
IWM

iShares Trust Russell 2000 Index Fund

$139.74 /

-3.32 (-2.32%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IWM iShares Trust Russell 2000 Index Fund
$139.74 /

-3.32 (-2.32%)

IWM iShares Trust Russell 2000 Index Fund
$139.74 /

-3.32 (-2.32%)

Technical Analysis
Diamonds Fund ETF: Pivot points » 08:21
05/29/20
05/29
08:21
05/29/20
08:21
DIA

Diamonds Fund ETF

$254.40 /

-1.31 (-0.51%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIA Diamonds Fund ETF
$254.40 /

-1.31 (-0.51%)

DIA Diamonds Fund ETF
$254.40 /

-1.31 (-0.51%)

DIA Diamonds Fund ETF
$254.40 /

-1.31 (-0.51%)

Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points » 08:21
05/29/20
05/29
08:21
05/29/20
08:21
SPY

SPDR S&P 500 ETF Trust

$303.07 /

-0.45 (-0.15%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

SPY SPDR S&P 500 ETF Trust
$303.07 /

-0.45 (-0.15%)

Technical Analysis
Financial Select Sector: Pivot points » 08:21
05/29/20
05/29
08:21
05/29/20
08:21
XLF

Financial Select Sector

$23.68 /

-0.37 (-1.54%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLF Financial Select Sector
$23.68 /

-0.37 (-1.54%)

XLF Financial Select Sector
$23.68 /

-0.37 (-1.54%)

XLF Financial Select Sector
$23.68 /

-0.37 (-1.54%)

Technical Analysis
Market Vectors Semiconductor: Pivot points » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
SMH

Market Vectors Semiconductor

$138.07 /

-3.2 (-2.27%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMH Market Vectors Semiconductor
$138.07 /

-3.2 (-2.27%)

SMH Market Vectors Semiconductor
$138.07 /

-3.2 (-2.27%)

SMH Market Vectors Semiconductor
$138.07 /

-3.2 (-2.27%)

SMH Market Vectors Semiconductor
$138.07 /

-3.2 (-2.27%)

Hot Stocks
BeiGene presents Phase 3 data on tislelizumab combined with chemotherapy » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
BGNE

BeiGene

$162.99 /

+1.88 (+1.17%)

BeiGene announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

03/25/20 Piper Sandler
BeiGene Abraxane issue could take months to resolve, says Piper Sandler
03/13/20 Macquarie
BeiGene upgraded to Neutral from Underperform at Macquarie
03/03/20 Maxim
BeiGene price target lowered to $190 from $210 at Maxim
02/18/20 Goldman Sachs
BeiGene reinstated with a Buy at Goldman Sachs
BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

Technical Analysis
Invesco QQQ Trust: Pivot points » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
QQQ

Invesco QQQ Trust

$229.89 /

-0.4 (-0.17%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QQQ Invesco QQQ Trust
$229.89 /

-0.4 (-0.17%)

QQQ Invesco QQQ Trust
$229.89 /

-0.4 (-0.17%)

QQQ Invesco QQQ Trust
$229.89 /

-0.4 (-0.17%)

Recommendations
Dollar General price target raised to $190 from $175 at Loop Capital » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
DG

Dollar General

$184.09 /

-2.715 (-1.45%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

05/28/20 Wells Fargo
Wells says Dollar General 'in a league of its own' after 'standout quarter'
05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar General initiated with a Buy at Goldman Sachs
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

Technical Analysis
Nasdaq Composite: Pivot points » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
$COMP

Nasdaq Composite

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
$0.00 /

+ (+0.00%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:20
05/29/20
05/29
08:20
05/29/20
08:20
NDX

Nasdaq 100 Index

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

Hot Stocks
Bio-Path Holdings presents trial design of its Phase 2 study of BP1001 at ASCO » 08:19
05/29/20
05/29
08:19
05/29/20
08:19
BPTH

Bio-Path Holdings

$5.60 /

-0.13 (-2.27%)

Bio-Path Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPTH Bio-Path Holdings
$5.60 /

-0.13 (-2.27%)

BPTH Bio-Path Holdings
$5.60 /

-0.13 (-2.27%)

05/18/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $18 from $25 at H.C. Wainwright
07/16/19 H.C. Wainwright
Bio-Path Holdings initiated with a Buy at H.C. Wainwright
BPTH Bio-Path Holdings
$5.60 /

-0.13 (-2.27%)

Hot Stocks
Gossamer Bio announces presentation of KEYNOTE-A36 Phase 1/2 study data at ASCO » 08:19
05/29/20
05/29
08:19
05/29/20
08:19
GOSS

Gossamer Bio

$12.10 /

+0.19 (+1.60%)

Gossamer Bio announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOSS Gossamer Bio
$12.10 /

+0.19 (+1.60%)

GOSS Gossamer Bio
$12.10 /

+0.19 (+1.60%)

05/20/20 SVB Leerink
Gossamer Bio price target raised to $36 from $27 at SVB Leerink
04/22/20 Piper Sandler
Gossamer Bio initiated with an Overweight at Piper Sandler
02/27/20 Barclays
Gossamer Bio initiated with an Overweight at Barclays
12/17/19 Cantor Fitzgerald
Gossamer Bio price target lowered to $25 from $34 at Cantor Fitzgerald
GOSS Gossamer Bio
$12.10 /

+0.19 (+1.60%)

GOSS Gossamer Bio
$12.10 /

+0.19 (+1.60%)

Recommendations
Advanced Drainage price target raised to $43 from $27 at Morgan Stanley » 08:18
05/29/20
05/29
08:18
05/29/20
08:18
WMS

Advanced Drainage

$44.78 /

-0.115 (-0.26%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMS Advanced Drainage
$44.78 /

-0.115 (-0.26%)

WMS Advanced Drainage
$44.78 /

-0.115 (-0.26%)

05/22/20 Baird
Advanced Drainage price target raised to $51 from $40 at Baird
05/22/20 Barclays
Advanced Drainage price target raised to $48 from $41 at Barclays
04/17/20 Baird
Advanced Drainage price target raised to $40 from $38 at Baird
12/20/19 Morgan Stanley
Advanced Drainage initiated with an Equal Weight at Morgan Stanley
WMS Advanced Drainage
$44.78 /

-0.115 (-0.26%)

Recommendations
Zscaler price target raised to $105 from $65 at DA Davidson » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

07:39 Today Cowen
Zscaler price target raised to $100 from $80 at Cowen
07:16 Today Wedbush
Zscaler price target raised to $100 from $80 at Wedbush
06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
06:14 Today Citi
Zscaler price target raised to $86 from $49 at Citi
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Hot Stocks
Marker Therapeutics reports results from MultiTAA-specific T cell therapy » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
MRKR

Marker Therapeutics

$2.48 /

-0.03 (-1.20%)

Marker Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

05/12/20
Fly Intel: Top five analyst downgrades
05/12/20 Piper Sandler
Marker Therapeutics downgraded to Neutral from Overweight at Piper Sandler
02/11/20 Roth Capital
Roth Capital maintains Buy on Marker Therapeutics after trial hold is lifted
02/11/20 Piper Sandler
Marker Therapeutics price target trimmed to $5 at Piper Sandler on study delay
MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

Initiation
Bandwidth assumed with a Buy at Canaccord » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
BAND

Bandwidth

$104.83 /

+0.07 (+0.07%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

05/11/20
Fly Intel: Top five analyst initiations
05/11/20 William Blair
Bandwidth initiated with an Outperform at William Blair
05/11/20 William Blair
Bandwidth initiated with an Outperform at William Blair
05/01/20 Needham
Bandwidth price target raised to $96 from $85 at Needham
BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

Hot Stocks
Comcast, Charter, ViacomCBS announce Blockgraph partnership » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
CMCSA

Comcast

$39.55 /

-0.37 (-0.93%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, CHTR

Charter

$535.17 /

+10.02 (+1.91%)

, VIAC

ViacomCBS

$21.21 /

-0.8 (-3.63%)

, VIACA

ViacomCBS

$25.33 /

-0.65 (-2.50%)

Comcast Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

05/19/20
Fly Intel: Top five analyst downgrades
05/19/20 Guggenheim
Guggenheim downgrades Comcast to Neutral on challenging 'new normal'
05/19/20 Guggenheim
Comcast downgraded to Neutral from Buy at Guggenheim
05/01/20
Fly Intel: Top five analyst downgrades
CMCSK Comcast
$0.00 /

+ (+0.00%)

04/28/20 Wells Fargo
SeaWorld price target lowered to $16 from $36 at Wells Fargo
04/17/20 Oppenheimer
Comcast downgraded to Perform from Outperform at Oppenheimer
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CHTR Charter
$535.17 /

+10.02 (+1.91%)

05/08/20 Benchmark
Charter price target raised to $600 from $523 at Benchmark
05/04/20 JPMorgan
Charter price target raised to $575 from $550 at JPMorgan
05/04/20 KeyBanc
Charter price target raised to $604 from $576 at KeyBanc
05/04/20 Pivotal Research
Charter price target raised to $700 from $625 at Pivotal Research
VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

05/11/20
Fly Intel: Top five analyst upgrades
05/11/20 Barrington
Barrington upgrades ViacomCBS on 'significant upside' potential
05/11/20 Barrington
ViacomCBS upgraded to Outperform from Market Perform at Barrington
05/08/20 JPMorgan
ViacomCBS risk/reward attractive after positive updates, says JPMorgan
VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

Hot Stocks
Gilead announces updated results from magrolimab trial » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
GILD

Gilead

$75.37 /

+0.42 (+0.56%)

Gilead announced updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/27/20 RBC Capital
Pullback in Gilead stock offers more attractive opportunity, says RBC Capital
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.